Serious adverse events: Shock, anaphylaxis symptoms (frequency unknown): Fully observe and stop the administration and treat appropriately if any of these symptoms appear.
Leukopenia (rare), thrombocytopenia (frequency unknown): Fully observe and stop the administration and treat appropriately if any of these symptoms appear.
Liver dysfunction (rare), jaundice (frequency unknown): Fully observe and stop the administration and treat appropriately if any of these symptoms occur accompanied by a rise in the AST, ALT, gamma-GTP, ALP.
Other adverse reaction: Hypersensitivity: Stop the administration if any of hypersensitivity such as hives, rashes, itching, and eczema appear.
Nervous system: Numbness, dizziness, drowsiness may occur.
Gastrointestinal: Dry mouth, constipation, rarely bloating, diarrhea, nausea, vomiting, heartburn, abdominal pain, belching, taste abnormalities may occur.
Liver: Stop the administration and treat appropriately if there is rise in AST, ALT, gamma-GTP, ALP or fever, rash appear at the same time.
Blood system: Thrombocytopenia, leukocyte sequestration (sometimes), rise in lymphocytes, leucopenia (rare), reduction of granulocytopenia may occur.
Others: Gynecomastia, galactorrhea, palpitations, fever, facial flushing, numbness of the tongue, cough, shortness of breath, hair loss, menstrual disorders or elevated BUN (rare), swelling, foreign body sensation in pharyngeal may occur.
View ADR Reporting Link